Il­lu­mi­na forced to pay al­most $334M as it los­es DNA se­quenc­ing patent case

A fed­er­al ju­ry in Delaware on Fri­day or­dered Il­lu­mi­na to pay Com­plete Ge­nomics Inc., a sub­sidiary of the BGI Group, the world’s largest mak­er of com­mer­cial ge­net­ic se­quencers, al­most $334 mil­lion, find­ing Il­lu­mi­na in­fringed on two DNA se­quenc­ing patents.

The case, be­gan in 2019 when CGI sued the San Diego-based biotech over the patents, al­leg­ing that Il­lu­mi­na’s “two-chan­nel” se­quenc­ing sys­tem and its kits that pre­pare DNA frag­ments for se­quenc­ing vi­o­lat­ed CGI’s patent rights.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.